Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Immunother. 2010 Nov–Dec;33(9):983–990. doi: 10.1097/CJI.0b013e3181f3cbf4

Table 1.

Characteristics of enrolled study population

Gender (%)
        Male 17 (73.9)
        Female 6 (26.1)
Mean age at enrollment, years (range) 29.2 (11 - 63)
Ethnic origin (%)
        African-American 6 (26.1)
        Asian 4 (17.4)
        Caucasian 11 47.8)
        Hispanic 1 (4.4)
        Native American 1 (4.4)
Disease status at 1st CTL infusion (%)
        Remission 8 (34.8)
        Local-Regional 3 (13.0)
        Unknown 2 (8.7)
        Metastatic 10 (43.5)
Mean number of chemotherapy regimens prior to study enrollment (range) 2.6 (1-6)